Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAI3 | P08754 | 6/20 | 0.97 |
| ▸ | GNAO1 | P09471 | 6/20 | 0.97 |
| ▸ | GNAI1 | P63096 | 6/20 | 0.97 |
| ▸ | NAAA | Q02083 | 1/20 | 0.71 |
| ▸ | PRCP | P42785 | 3/20 | 0.64 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL20542952 | 0.98 | GNAI3 (1.00) | GNAI3GNAO1GNAI1NAAAPRCP | |
| SCHEMBL4555068 | 0.98 | GNAI3 (0.94) | GNAI3GNAO1GNAI1NAAAPRCP | |
| SCHEMBL1438748 | 0.93 | GNAI3 (0.84) | GNAI3GNAO1GNAI1NAAAPRCP | |
| SCHEMBL19064233 | 0.91 | GNAI3 (0.81) | GNAI3GNAO1GNAI1NAAAPRCP | |
| SCHEMBL22178791 | 0.90 | GNAI3 (0.80) | GNAI3GNAO1GNAI1NAAAPRCP | |
| SCHEMBL22179371 | 0.90 | GNAI3 (0.80) | GNAI3GNAO1GNAI1NAAAPRCP | |
| SCHEMBL22179122 | 0.90 | GNAI3 (0.80) | GNAI3GNAO1GNAI1NAAAPRCP | |
| SCHEMBL22179378 | 0.90 | GNAI3 (0.80) | GNAI3GNAO1GNAI1NAAAPRCP | |
| SCHEMBL22178856 | 0.90 | GNAI3 (0.80) | GNAI3GNAO1GNAI1NAAAPRCP | |
| SCHEMBL22178792 | 0.90 | GNAI3 (0.80) | GNAI3GNAO1GNAI1NAAAPRCP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118666840-A | Design synthesis and application of spiro [ pyrrolidine-3, 3 '-quinoline ] -2,2' -diketopiperidine carboxamide compound | 西南大学 | 2024-09-20 | — | — | CN | disclosed |
| US-9908872-B2 | Methods to treat lymphoplasmacytic lymphoma | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2018-03-06 | — | — | US | disclosed |
| WO-2009098282-A1 | LOW MOLECULAR WEIGHT 2,5-DISUBSTITUTED THIOPHENE DERIVATIVES AND USE THEREOF IN THERAPY | NOVASAID AB (SE) | 2009-08-13 | — | — | WO | disclosed |
| EP-1720874-A1 | 4-SUBSTITUTED PIPERIDINE DERIVATIVES | Bioaxone Therapeutique Inc. (CA) | 2006-11-15 | — | — | EP | disclosed |
| WO-2005080394-A1 | 4-SUBSTITUTED PIPERIDINE DERIVATIVES | BIOAXONE THERAPEUTIQUE INC. (CA) | 2005-09-01 | — | — | WO | disclosed |